FULCRUM THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
FULCRUM THERAPEUTICS, INC. (FULC) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$2.06 million for the 6-month period ending 2026-06-30, per its S-4 filed 2026-09-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-09-02
- FULCRUM THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$2.24M, a 878.47% decline year-over-year.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $179.00K.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$44.00K, a 121.26% decline year-over-year.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$44.00K, a 101.82% decline year-over-year.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $1.07M, a 530.59% increase from fiscal 2022.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $170.00K, a 26.87% increase from fiscal 2021.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2021 was $134.00K, a 80.77% decline from fiscal 2020.
- FULCRUM THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2020 was $697.00K, a 71.66% decline from fiscal 2019.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.24M derived: S-4 6 month − 10-Q 3 month · filed 2026-09-02 | -$2.06M S-4 · filed 2026-09-02 | -$2.11M derived: sum of 3 quarters · filed 2026-09-02 | -$2.15M derived: sum of 4 quarters · filed 2026-09-02 | ||
| 2026-03-31 | $179.00K 10-Q · filed 2026-04-27 | $135.00K derived: sum of 2 quarters · filed 2026-09-02 | $91.00K derived: sum of 3 quarters · filed 2026-09-02 | $379.00K derived: sum of 4 quarters · filed 2026-09-02 | ||
| 2025-12-31 | -$44.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-02 | -$88.00K derived: sum of 2 quarters · filed 2026-09-02 | $200.00K derived: sum of 3 quarters · filed 2026-09-02 | -$1.63M S-4 · filed 2026-09-02 | ||
| 2025-09-30 | -$44.00K derived: 10-Q 9 month − S-4 6 month · filed 2025-10-29 | $244.00K derived: sum of 2 quarters · filed 2026-09-02 | -$1.59M 10-Q · filed 2025-10-29 | -$1.38M derived: sum of 4 quarters · filed 2026-09-02 | ||
| 2025-06-30 | $288.00K derived: S-4 6 month − 10-Q 3 month · filed 2026-09-02 | -$1.54M S-4 · filed 2026-09-02 | -$1.34M derived: sum of 3 quarters · filed 2026-09-02 | $1.09M derived: sum of 4 quarters · filed 2026-09-02 | ||
| 2025-03-31 | -$1.83M 10-Q · filed 2026-04-27 | -$1.63M derived: sum of 2 quarters · filed 2026-09-02 | $799.00K derived: sum of 3 quarters · filed 2026-09-02 | $336.00K derived: sum of 4 quarters · filed 2026-09-02 | ||
| 2024-12-31 | $207.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-02 | $2.63M derived: sum of 2 quarters · filed 2026-09-02 | $2.17M derived: sum of 3 quarters · filed 2026-09-02 | $1.36M S-4 · filed 2026-09-02 | ||
| 2024-09-30 | $2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.96M derived: sum of 2 quarters · filed 2025-10-29 | $1.16M 10-Q · filed 2025-10-29 | $1.78M derived: sum of 4 quarters · filed 2025-10-29 | ||
| 2024-06-30 | -$463.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$1.27M 10-Q · filed 2025-07-29 | -$644.00K derived: sum of 3 quarters · filed 2025-07-29 | $48.00K derived: sum of 4 quarters · filed 2025-07-29 | ||
| 2024-03-31 | -$803.00K 10-Q · filed 2025-05-01 | -$181.00K derived: sum of 2 quarters · filed 2025-05-01 | $511.00K derived: sum of 3 quarters · filed 2025-05-01 | -$253.00K derived: sum of 4 quarters · filed 2025-05-01 | ||
| 2023-12-31 | $622.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.31M derived: sum of 2 quarters · filed 2025-02-25 | $550.00K derived: sum of 3 quarters · filed 2025-02-25 | $1.07M 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $692.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$72.00K derived: sum of 2 quarters · filed 2024-11-13 | $450.00K 10-Q · filed 2024-11-13 | -$316.00K derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | -$764.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$242.00K 10-Q · filed 2024-07-31 | -$1.01M derived: sum of 3 quarters · filed 2024-07-31 | -$97.00K derived: sum of 4 quarters · filed 2024-07-31 | ||
| 2023-03-31 | $522.00K 10-Q · filed 2024-05-13 | -$522.00K 10-Q · filed 2023-05-15 | -$244.00K derived: sum of 2 quarters · filed 2024-05-13 | $667.00K derived: sum of 3 quarters · filed 2024-05-13 | $596.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | -$766.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $145.00K derived: sum of 2 quarters · filed 2024-02-27 | $74.00K derived: sum of 3 quarters · filed 2024-02-27 | $170.00K 10-K · filed 2024-02-27 | ||
| 2022-09-30 | $911.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $840.00K derived: sum of 2 quarters · filed 2023-11-07 | $936.00K 10-Q · filed 2023-11-07 | $500.00K derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | -$71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $25.00K 10-Q · filed 2023-08-03 | -$25.00K 10-Q · filed 2022-08-11 | -$411.00K derived: sum of 3 quarters · filed 2023-08-03 | $1.93M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | $96.00K 10-Q · filed 2023-05-15 | -$96.00K 10-Q · filed 2022-05-09 | -$340.00K derived: sum of 2 quarters · filed 2023-06-26 | $2.00M derived: sum of 3 quarters · filed 2023-06-26 | $1.70M derived: sum of 4 quarters · filed 2023-06-26 | |
| 2021-12-31 | -$436.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-26 | $1.91M derived: sum of 2 quarters · filed 2023-06-26 | $1.60M derived: sum of 3 quarters · filed 2023-06-26 | $134.00K 10-K/A · filed 2023-06-26 | ||
| 2021-09-30 | $2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.04M derived: sum of 2 quarters · filed 2022-11-08 | $570.00K 10-Q · filed 2022-11-08 | $141.00K derived: sum of 4 quarters · filed 2023-06-26 | ||
| 2021-06-30 | -$307.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$1.77M 10-Q · filed 2022-08-11 | -$2.20M derived: sum of 3 quarters · filed 2023-06-26 | $3.00K derived: sum of 4 quarters · filed 2023-06-26 | ||
| 2021-03-31 | -$1.47M 10-Q · filed 2022-05-09 | -$1.90M derived: sum of 2 quarters · filed 2023-06-26 | $310.00K derived: sum of 3 quarters · filed 2023-06-26 | -$190.00K derived: sum of 4 quarters · filed 2023-06-26 | ||
| 2020-12-31 | -$429.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-26 | $1.78M derived: sum of 2 quarters · filed 2023-06-26 | $1.28M derived: sum of 3 quarters · filed 2023-06-26 | $697.00K 10-K/A · filed 2023-06-26 | ||
| 2020-09-30 | $2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.71M derived: sum of 2 quarters · filed 2021-11-04 | $1.13M 10-Q · filed 2021-11-04 | $871.00K derived: sum of 4 quarters · filed 2023-06-23 | ||
| 2020-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$1.08M 10-Q · filed 2021-08-10 | -$1.33M derived: sum of 3 quarters · filed 2023-06-23 | $552.00K derived: sum of 4 quarters · filed 2023-06-23 | ||
| 2020-03-31 | -$579.00K 10-Q · filed 2021-05-06 | -$834.00K derived: sum of 2 quarters · filed 2023-06-23 | $1.05M derived: sum of 3 quarters · filed 2023-06-23 | $1.62M derived: sum of 4 quarters · filed 2023-06-23 | ||
| 2019-12-31 | -$255.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-23 | $1.63M derived: sum of 2 quarters · filed 2023-06-23 | $2.19M derived: sum of 3 quarters · filed 2023-06-23 | $2.46M 10-K/A · filed 2023-06-23 | ||
| 2019-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $2.45M derived: sum of 2 quarters · filed 2020-11-10 | $2.71M 10-Q · filed 2020-11-10 | $2.73M derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $564.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $828.00K 10-Q · filed 2020-08-11 | $839.00K derived: sum of 3 quarters · filed 2020-08-11 | $838.00K derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | $264.00K 10-Q · filed 2020-05-13 | $275.00K derived: sum of 2 quarters · filed 2020-05-13 | $274.00K derived: sum of 3 quarters · filed 2020-05-13 | |||
| 2018-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $10.00K derived: sum of 2 quarters · filed 2020-03-05 | $40.00K 10-K · filed 2020-03-05 | |||
| 2018-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $29.00K 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | $30.00K 10-Q · filed 2019-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |